Pharmaceutical companies Pfizer and Moderna are now required by the U.S. Food and Drug Administration (FDA) to update their COVID‑19 vaccine labels to include stronger warnings about a rare risk of heart inflammation—myocarditis and pericarditis—especially in young males. The new

Continue ReadingCOVID vaccine heart inflammation risk.